Therefore, this review aims to elucidate the therapeutic advancements and strategies involving PD-1/PD-L1 inhibitors in early- and intermediate-stage microsatellite-high and stable colorectal cancer, with the objective of offering broader therapeutic options for patients in these stages. The gene discussed is CD274; the disease is colorectal cancer.